Recent genetic studies have revealed that many functionally defined and some undefined NQO2 polymorphisms can alter cancer susceptibility and progression, modify the response to chemotherapy, but also may predispose to Parkinson’s disease and certain neurological dysfunctions. The gene discussed is NQO2; the disease is Parkinson disease.